Cre recombinase-mediated inactivation of H-2Dd transgene expression: Evidence for partial missing self-recognition by Ly49A NK cells

Journal of Immunology

Volumn 167, Issue 11, 2001, Pages 6256-6262

  Ioannidis, V ^a   Zimmer, J ^a   Beermann, F ^a   Held, W ^a  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CRE RECOMBINASE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY TEST; FLOW CYTOMETRY; GENE CONSTRUCT; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE INACTIVATION; H 2D D TRANSGENE; IMMUNOGENETICS; MOUSE; NATURAL KILLER CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TRANSGENE; TRANSGENIC MOUSE;

EID: 0035575730     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.11.6256     Document Type: Article

References (36)

1. Direct assessment of MHC class I binding by seven Ly49 inhibitory NK cell receptors
2. + IL-2 activated natural killer cells
3. Regulation of the natural killer cell receptor repertoire
4. MHC class I deficiency: Susceptibility to natural killer (NK) cells and impaired NK activity
5. - bone marrow in chimeric mice
6. Development and tolerance of natural killer cells
7. Class I-deficient hemopoietic cells and nonhemopoietic cells dominantly induce unresponsiveness of natural killer cells to class I-deficient bone marrow cell grafts
8. Prevention of allogeneic bone marrow graft rejection by H-2 transgene in donor mice
9. Transgenic expression of the Ly49A natural killer cell receptor confers class I major histocompatibility complex (MHC)-specific inhibition and prevents bone marrow allograft rejection
10. Natural killer cell acceptance of H-2 mismatch bone marrow grafts in transgenic mice expressing HLA-Cw3 specific killer cell inhibitory receptor
11. Ly49I NK cell receptor transgene inhibition of rejection of H2b mouse bone marrow transplants
12. Altered phenotype and function of natural killer cells expressing the major histocompatibility complex receptor Ly-49 in mice transgenic for its ligand
13. Major histocompatibility complex genes determine natural killer cell tolerance
14. The role of Ly49A and 5E6 (Ly49C) molecules in hybrid resistance mediated by murine natural killer cells against normal T cell blasts
15. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors
16. Diversity of NK cell receptor repertoire in adult and neonatal mice
17. Natural killer cell tolerance in mice with mosaic expression of major histocompatibility complex class I molecules
18. Host MHC class I gene control of NK cell specificity in the mouse
19. Exon shuffling: Mapping polymorphic determinants on hybrid mouse transplantation antigens
20. Inducible gene targeting in mice
21. Ligand-activated site-specific recombination in mice
22. Hybrid resistance in vitro: Possible role of both class I MHC and self peptides in determining the level of target cell sensitivity
23. Fine tuning of natural killer cell specificity and maintenance of self tolerance in MHC class I-deficient mice
24. IFN-γ production and cytotoxicity of IL-2-activated murine NK cells are differentially regulated by MHC class I molecules
25. d target cells leads to Dap-12 phosphorylation and IFN-γ secretion
26. Cloning and functional characteristics of murine LGL-I: A member of the Ly-49 gene family (Ly-49G2)
27. Cumulative inhibition of NK cells and T cells resulting from engagement of multiple inhibitory Ly49 receptors
28. Positive impact of inhibitory Ly49 receptor-MHC class I interaction on NK cell development
29. + T cells
30. Human and mouse killer-cell inhibitory receptors recruit PTPIC and PTPID protein tyrosin phosphatases
31. Immune signaling: SHP-2 docks at multiple ports
32. LCK-phosphorylated human killer cell-inhibitory receptors recruit and activate phosphatidylinositol 3-kinase
33. Signaling by distinct classes of phosphoinositide 3-kinases
34. d transgene
35. d transgene to C57BL mice
36. Restoration of a tumorigenic phenotype by β-microglobulin transfection to EL-4 mutant cells